Drug Database · Clinicians

Cefepime + Sulbactam

Brands (5) Carpime, Gocifime, Novafime S…Show all

Antibacterial (Cephalosporin/Beta-lactamase inhibitor) PH FDA category
Fixed-dose combination.

Rx · Prescription drug5 PH products
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: Cefepime for Injection is a cephalosporin antibacterial indicated for the treatment of the following infections caused by susceptible strains of the designated microorganisms: Pneumonia. US FDA label

    Kidney dosing: Cefepime (single-agent)
    Show full dosing details
    CrCl ≥60 mL/min
    CrCl >60: usual dose (label: 500 mg to 2 g every 8 to 12 hours by indication). CrCl of exactly 60: use the 30–60 row.
    CrCl 30–59 mL/min
    CrCl 30–60, by usual regimen: 500 mg q12h → 500 mg q24h; 1 g q12h → 1 g q24h; 2 g q12h → 2 g q24h; 2 g q8h → 2 g q12h. First dose as for normal function (label Table 2).
    CrCl 15–29 mL/min
    CrCl 11–29, by usual regimen: 500 mg q12h → 500 mg q24h; 1 g q12h → 500 mg q24h; 2 g q12h → 1 g q24h; 2 g q8h → 2 g q24h (label Table 2).
    CrCl <15 mL/min (not on dialysis)
    CrCl 11–14: as the 11–29 row. CrCl below 11, by usual regimen: 250 mg, 250 mg, 500 mg or 1 g every 24 hours respectively (label Table 2).
    Hemodialysis (intermittent)
    1 g on day 1, then 500 mg every 24 hours; for the 2 g every 8 hours regimen (febrile neutropenia) 1 g every 24 hours; give at the same time each day and after hemodialysis on dialysis days (label). A 3-hour session removes about 68% of the drug in the body. Literature option (not label): thrice-weekly after each session, 2 g, 2 g and 2 g (1/1/1.5 g and 1.5/1.5/2 g reported in limited data) (Tsai 2025). Troughs of 22 mg/L or more have been associated with neurotoxicity; stop if encephalopathy or myoclonus appears. These regimens are not weight-adjusted and come mostly from small pharmacokinetic studies; confirm the actual last and next session before each dose. See the site guide Antibiotic Stewardship in Hemodialysis (/guides/antibiotic-stewardship-dialysis.html).
    Peritoneal dialysis
    CAPD: the usual dose every 48 hours (500 mg, 1 g, 2 g or 2 g by regimen) (label Table 2). For PD-associated peritonitis (ISPD 2022): intraperitoneal intermittent 1,000 mg daily; continuous loading dose 500 mg/L, then 125 mg/L in each exchange. Continuous cephalosporin doses may need about 25% more in patients with significant residual kidney function (ISPD 2022).
    CRRT
    Not in label. Li 2020 (Table 3): CVVH ultrafiltration 1,000 mL/h or less, 1 g every 8 hours; 1,500 mL/h or more, 2 g every 8 hours or 1 g every 6 hours; 30 mL/kg/h, 2 g every 8 hours as extended infusion. CVVHD dialysate 20–25 mL/kg/h, load 2 g, then 1.5–1.75 g every 8 hours. CVVHDF combined flow 1,000 mL/h or less, 1 g every 8 hours; 1,500 mL/h or more, 2 g every 8 hours or 1 g every 6 hours.
    • Dialyzable? Yes: about 68% removed during a 3-hour hemodialysis (label). For overdose the label advises hemodialysis, not peritoneal dialysis. Protein binding about 20%.
    • Monitoring CrCl for dose; neurotoxicity (encephalopathy, myoclonus, seizures, nonconvulsive status epilepticus), mainly with unadjusted doses in kidney impairment; stop cefepime if it occurs (label 5.2). Kidney function with aminoglycosides or loop diuretics.

    From the Cefepime monograph (renalcarematters.com, reviewed).

  • sulbactam no separate page

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Powder for injection: 1 g/500 mg, 1.5 g

Registered products in the Philippines

5 products registered with the Food and Drug Administration (FDA) Philippines list Cefepime + Sulbactam as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products5
Philippine FDA-registered products for Cefepime + Sulbactam
Package insert
CarpimeCefepime (as hydrochloride) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (IM/IV)Type I Glass Vial with Gray Bromobutyl Rubber Stopper and Flip off Seal x 1's (Box of 1's)
Rx
Swiss Parenterals Ltd.India
Best ClearImporter: Medinova Pharmaceutical Inc.
DRP-10890-01
Dec 14, 2026
GocifimeCefepime (as hydrochloride) + Sulbactam (as sodium)
1.5 g Powder for Injection (I.M./I.V)Type I Glass Vial with Gray Bromobutyl Rubber Stopper and Flip off seal x 1's (Box of 1's)
Rx
Swiss Parenterals Ltd.India
Applied Pharmaceutical Distribution Inc.Importer: Medinova Pharmaceutical Inc.
DRP-10890-04
Dec 14, 2026
Novafime SCefepime (as hydrochloride) + Sulbactam (as sodium)
1g/500 mg Powder for Injection (IM/IV)Type I Glass Vial with Gray Bromobutyl Rubber Stopper and Flip-Off Seal x l's (Box of l's)
Rx
Swiss Parenterals Ltd.India
Importer: Medinova Pharmaceutical, Inc.
DRP-10890
Dec 14, 2026
QuatamCefepime (as hydrochloride) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (I.M./I.V)Type I Glass Vial with Gray Bromobutyl Rubber Stopper and Flip off Seal x 1's (Box of 1's)
Rx
Swiss Parenterals Ltd.India
Zydus Healthcare Philippines Inc.Importer: Medinova Pharmaceutical Inc.
DRP-10890-03
Dec 14, 2026
Vezcepime-SCefepime (as hydrochloride) + Sulbactam (as sodium)
1 g/500 mg Powder for Injection (IM/IV)Type I Glass Vial with Gray Bromobutyl Rubber Stopper and Flip-Off Seal x 1's (Box of 1's)
Rx
Swiss Parenterals Ltd.India
Vezcell Drug Distribution ServicesImporter: Medinova Pharmaceutical Inc.
DRP-10890-05
Dec 14, 2026

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .